LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.82 | 17.25 | 153 | 800 | 0.1911 | 0.4833 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.82 | 17.25 | 976 | 800 | 1.2192 | 1.0729 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.79 | 17.25 | 982 | 1001 | 0.9804 | 0.9933 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.79 | 17.25 | 297 | 1001 | 0.2965 | 0.6253 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.79 | 17.25 | 980 | 1001 | 0.9784 | 0.9926 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.76 | 17.25 | 988 | 1193 | 0.8278 | 0.9391 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.76 | 17.25 | 318 | 1193 | 0.2664 | 0.6108 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.76 | 17.25 | 986 | 1193 | 0.8261 | 0.9385 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.73 | 17.25 | 974 | 1290 | 0.7549 | 0.9117 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.73 | 17.25 | 192 | 1290 | 0.1488 | 0.4727 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.73 | 17.25 | 979 | 1290 | 0.7588 | 0.9133 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.70 | 17.25 | 954 | 1466 | 0.6504 | 0.8702 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.70 | 17.25 | 153 | 1466 | 0.1043 | 0.4057 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.70 | 17.25 | 972 | 1466 | 0.6627 | 0.8757 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.67 | 17.25 | 926 | 1653 | 0.5602 | 0.8314 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.67 | 17.25 | 154 | 1653 | 0.0932 | 0.3945 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.67 | 17.25 | 948 | 1653 | 0.5735 | 0.8380 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.64 | 17.25 | 890 | 1887 | 0.4715 | 0.7899 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.64 | 17.25 | 138 | 1887 | 0.0731 | 0.3593 | MN20160310_N02 | K04 |